Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Harthug

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 10, 1996
[Treatment of hepatitis C]E Schrumpf, K Bjøro, H Bell, et al.
British Journal of Anaesthesia|February 14, 2013
Impact of the World Health Organization's Surgical Safety Checklist on safety culture in the operating theatre: a controlled intervention studyA S Haugen, E Søfteland, G E Eide, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 7, 2014
Prior statin use and 90-day mortality in Gram-negative and Gram-positive bloodstream infection: a prospective observational studyA Mehl, S Harthug, S Lydersen, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1996
Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct GroupH Bell, K Hellum, S Harthug, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 9, 1998
[Infections caused by multiresistant enterococci in Norway]S Harthug, N Langeland, A Digranes, et al.
Scandinavian Journal of Gastroenterology|April 7, 1999
Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT GroupH Bell, K Hellum, S Harthug, et al.
Scandinavian Journal of Gastroenterology|March 28, 1998
The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT GroupL M Jarvis, H Bell, P Simmonds, et al.
Scandinavian Journal of Infectious Diseases|March 5, 1999
Low faecal carrier rate of vancomycin resistant enterococci in Norwegian hospital patientsG S Simonsen, B M Andersen, A Digranes, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2003
Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitalsG S Simonsen, L Småbrekke, D L Monnet, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1997
Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct groupH Bell, K Hellum, S Harthug, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 10, 1996
[Treatment of hepatitis C]E Schrumpf, K Bjøro, H Bell, et al.
British Journal of Anaesthesia|February 14, 2013
Impact of the World Health Organization's Surgical Safety Checklist on safety culture in the operating theatre: a controlled intervention studyA S Haugen, E Søfteland, G E Eide, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 7, 2014
Prior statin use and 90-day mortality in Gram-negative and Gram-positive bloodstream infection: a prospective observational studyA Mehl, S Harthug, S Lydersen, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1996
Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct GroupH Bell, K Hellum, S Harthug, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 9, 1998
[Infections caused by multiresistant enterococci in Norway]S Harthug, N Langeland, A Digranes, et al.
Scandinavian Journal of Gastroenterology|April 7, 1999
Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT GroupH Bell, K Hellum, S Harthug, et al.
Scandinavian Journal of Gastroenterology|March 28, 1998
The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT GroupL M Jarvis, H Bell, P Simmonds, et al.
Scandinavian Journal of Infectious Diseases|March 5, 1999
Low faecal carrier rate of vancomycin resistant enterococci in Norwegian hospital patientsG S Simonsen, B M Andersen, A Digranes, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2003
Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitalsG S Simonsen, L Småbrekke, D L Monnet, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1997
Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct groupH Bell, K Hellum, S Harthug, et al.
Pageof 3